Previously, ginsenoside Rg3 was reported to attenuate cerebral ischemia/reperfusion injury by mitigating mitochondrial oxidative stress via the Nrf2/HO-1 signaling pathway [29]. The gene discussed is NFE2L2; the disease is brain ischemia.